Skip to main content

Table 1 Differential expression of genes involved in T-cell anergy and immune tolerance.

From: Semi-allogeneic vaccines and tumor-induced immune tolerance

GENE

FUNCTION

Fold UP-Regulation

(DOWN-Regulation)

BTLA

Induced during activation of T cells;

Expressed on Th1 cells;

Interacts with B7 homolog B7H4.

3.0; 2.7

CD40

Co-stimulatory molecule expressed by B cells, dendritic cells, and follicular dendritic cells.

2.6; 2.7

CD40L

Expressed by activated T cells;

Binds to CD40 on APC.

1.6, 2.1

CD70

Expressed by activated T and B cells;

Induces proliferation of co-stimulated T cells;

Enhances the generation of CTLs.

3.0, 1.7

FASLG

Interacts with FAS and triggers apoptosis.

2.1, 2.2

GZMB

Granzyme B is crucial for apoptosis of target

Cells by CTLs.

3.2, 2.4

HDAC9

Histone deacetylase 9, transcriptional repressor.

3.4, 2.7

ICOS

Inducible T-cell co-stimulator.

2.2, 1.7

IFNG

Th1- and dendritic cell-specific cytokine.

5.5

LTA

Lymphotoxin α or tumor necrosis factor β.

2.1, 1.7

PRF1

Perforin, key CTL effector molecule.

2.4, 2.6

TBX21

Th1-specific transcription factor that controls the

expression of IFN-γ.

2.6

TNFRSF4

Receptor involved in CD4+ T cell response.

2.0, 2.1

TNFSF10

TNF-like cytokine;

Induces apoptosis of tumor cells.

2.1, 1.6

TNFSF8

TNF-like cytokine;

Induces apoptosis of some lymphoma cells.

2.1, 1.7

CCR4

Receptor for CC chemokines.

(2.9, 2.0)

GATA3

Transcription factor that favors expression of

Th2-type cytokines.

(2.4, 1.5)

IL5

Cytokine for growth and differentiation of B cells

and eosinophils.

(1.3, 4.1)

IL6

Inhibits T cell activation;

Inhibits the CD40L system;

Induces a Th2-type cytokine response.

(5.9, 6.7)

LAT

Required for TCR-mediated signaling;

Possibly associated with overstimulation and

apoptosis of T cells.

(2.8, 2.1)

PDCD1

Induction and maintenance of T-cell tolerance.

(2.7, 2.0)

RNF128

Involved in induction of anergic phenotype

(5.4, 4.5)

TNFRSF8

Positive regulator of apoptosis;

Limits proliferation of CD+ effector T cells.

(4.7, 2.8)

  1. Expression was measured by real-time RT-PCR. Total RNA was purified from splenocytes of vaccinated immune mice and compared to RNA from control, non-immune mice.